Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 19 Insulin Resistance 5 Infertility 3 Hyperandrogenism 3 Anovulation 3 Glucose Intolerance 2 Carcinoma, Non-Small-Cell Lung 2 Weight Loss 1 Small Cell Lung Carcinoma 1 Precancerous Conditions 1 Metabolic Syndrome 1 Menstruation Disturbances 1 Lung Neoplasms 1 Inflammation 1 Infertility, Female 1 Hodgkin Disease 1

Interventions

Exercise 5 Vitamin D 2 Tea 2 Sufentanil 2 Spironolactone 2 Probiotics 2 Oxycodone 2 Omeprazole 2 Morphine 2 Metformin 2 Etanercept 2 Colchicine 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 salicylsalicylic acid 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tumor Necrosis Factors 1 Tranexamic Acid 1 Tobramycin 1 Sulindac 1 Sodium Salicylate 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Inflammation × Inositol × Clear all

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡